Ontology highlight
ABSTRACT:
SUBMITTER: O'Neilla C
PROVIDER: S-EPMC4843962 | biostudies-literature | 2010 Jul
REPOSITORIES: biostudies-literature
O'Neilla Ciaragh C Jones Sophie C P SCP Bossé Janine T JT Watson Conrad M CM Williamson Susanna M SM Rycroft Andrew N AN Simon Kroll J J Hartley Helen M HM Langford Paul R PR
Vaccine 20100516 31
APXIVA is an RTX toxin of Actinobacillus pleuropneumoniae that is a candidate antigen to differentiate infected from vaccinated animals (DIVA). Insertion of ISApl1 into the apxIVA gene is known to compromise an APXIVA-based DIVA approach, as is potentially a TGG to TGA mutation in the apxIVA gene. ISApl1 was found in 63/349 (18.1%) A. pleuropneumoniae isolates from England and Wales including serovars 2, 3, 6-8 and 12. No ISApl1 insertions into apxIVA were found. Only two serovar 3 isolates cont ...[more]